Analyst firms · BofA Securities · PHVS

BofA Securities PHVS price target and rating history

Pharvaris N.V. (PHVS) · Health Care

BofA Securities rates Pharvaris N.V. (PHVS) Buy with a $44 price target, as of its latest action on Oct 23, 2026. It has published 3 rating actions on PHVS since August 2022, including 2 upgrades and 1 downgrade. Across 4 firms with a PHVS price target in the last 12 months, the median target is $48. BofA Securities's $44 is 8% below that.

Current rating
Buy
Price target
$44
Median target, all firms
$48
Actions on PHVS
3

BofA Securities price target on PHVS

$44$29$132023202420252026
BofA Securities price target on PHVS, each point a stated target, August 2022 to October 2026.

Every BofA Securities rating on PHVS

How other firms rate PHVS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesBuy$44Oct 23, 2026
Wells FargoOverweight$55Jul 15, 2026
Wolfe ResearchOutperform$42Apr 9, 2026
RBC Capital MarketsOutperform$52Mar 9, 2026

Questions about BofA Securities and PHVS

What is BofA Securities's price target for PHVS?
BofA Securities's latest stated price target for Pharvaris N.V. (PHVS) is $44, from its action on Oct 23, 2026.
What is BofA Securities's rating on PHVS?
BofA Securities rates PHVS Buy, a bullish rating, as of Oct 23, 2026.
When did BofA Securities last change its view on PHVS?
On Oct 23, 2026, BofA Securities upgrades to Buy from Neutral, price target $44.
How does BofA Securities's PHVS target compare with other analysts?
Across 4 firms with a PHVS price target in the last 12 months, the median target is $48. BofA Securities's $44 is 8% below that.

All BofA Securities ratingsPHVS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.